» Articles » PMID: 16006472

Cell-free Fetal DNA Levels in Pregnancies Conceived by IVF

Overview
Journal Hum Reprod
Date 2005 Jul 12
PMID 16006472
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Increased second-trimester levels of maternal serum HCG in IVF conceptions lead to an increased false-positive rate in Down syndrome screening. Increased levels of cell-free fetal DNA (cffDNA) in maternal plasma have been correlated with increased HCG levels. Our aim was to determine whether cffDNA levels are elevated in IVF pregnancies compared with natural pregnancies.

Methods: Sixteen archived second-trimester serum samples from IVF pregnancies were matched with five control samples from naturally conceived pregnancies per case, all carrying a singleton male fetus. cffDNA concentrations were measured by real-time PCR amplification of a Y chromosome sequence and compared with four standard second trimester serum screening markers (alpha-fetoprotein, estriol, HCG and inhibin A).

Results: Mean cffDNA levels for cases and controls were 57.9 and 57.1 genome equivalents/ml, respectively (P = 0.95). Mean observed rank (from 1 to 6) of cffDNA was 3.625 in the IVF conceived group, compared with an expected value of 3.5 (P = 0.53). No significant correlations were observed between cffDNA and serum markers.

Conclusions: IVF does not affect levels of cffDNA, which appears to be independent of traditional screening markers (e.g. HCG). Therefore, cffDNA can be used as an additional serum marker (e.g. Down syndrome screening) without adjustment for IVF pregnancies.

Citing Articles

Comparison of the Fetal Fraction of Cell-Free DNA in In-Vitro Fertilization (IVF) Versus Natural Conception Evaluation of the Fetal Fraction With IVF Parameters.

Kallianidis K, Dimitroulia E, Mavrogianni D, Liokari E, Bletsa R, Anagnostou E Cureus. 2022; 14(4):e24516.

PMID: 35651460 PMC: 9136190. DOI: 10.7759/cureus.24516.


Role of Male Factor Testing in Recurrent Pregnancy Loss or Fertilization Failure.

Dickey R, Ramasamy R Reprod Syst Sex Disord. 2015; 4(3):1000e122.

PMID: 26500807 PMC: 4617559. DOI: 10.4172/2161-038X.1000e122.


Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis.

Devaney S, Palomaki G, Scott J, Bianchi D JAMA. 2011; 306(6):627-36.

PMID: 21828326 PMC: 4526182. DOI: 10.1001/jama.2011.1114.


Relationships between cell-free DNA and serum analytes in the first and second trimesters of pregnancy.

Vora N, Johnson K, Lambert-Messerlian G, Tighiouart H, Peter I, Urato A Obstet Gynecol. 2010; 116(3):673-678.

PMID: 20733451 PMC: 2975594. DOI: 10.1097/AOG.0b013e3181ea2dd1.


Correlation between serum biochemical markers and early amniocentesis in diagnosis of congenital fetal anomalies.

Loncar D, Varjacic M, Novakovic T, Milovanovic D, Jankovic S Bosn J Basic Med Sci. 2010; 10(1):9-14.

PMID: 20192924 PMC: 5596620. DOI: 10.17305/bjbms.2010.2726.